Abstract
ABSTRACT
Introduction: hypertensive disorders are the most common medical complication of pregnancy, with a global prevalence of 5-10%, and are one of the most important causes of morbidity and mortality, especially in eveloping countries. There is little information about the evaluation, treatment and complications associated with postpartum hypertension, and the lack of management guidelines can result in imprecise diagnosis and incorrect therapeutic approaches. Objective: to provide an approach about the benefits and risks associated
with the pharmacological management of postpartum hypertension. Searching methodology: a literature review was conducted using the bibliographic databases PubMed, Science Direct, Embase, SciELO and LILACS, limiting the search to articles published in the last 10 years, in Spanish and English. We excluded the articles that did not contained information about the clinical presentation, treatment or complications associated with postpartum hypertension. Results: a total of 69 articles that met the inclusion criteria were obtained. Discussion and Conclusion: due to the limited literature about the management of postpartum hypertension, it is not accurate to speak of first-line drugs. The choice of a drug is guided by the underlying etiology and factors such as breastfeeding should be taken into account. The proposed drugs belong to groups of calcium channel antagonists, β-blockers, renin-angiotensin-aldosterone axis antagonists, iuretics, α-blockers, among others. It is noted that the most used drugs are nifedipine, methyldopa, and β-blockers such as propranolol nd labetalol, because of the evidence supporting the safety of their use during the postpartum period. MÉD.UIS. 2016;29(2):71-80.
Keywords: Pregnancy Induced Hypertension. Postpartum period. Antihypertensive agents. Therapeutics.
References
Sibai BM. Etiology and management of postpartum hypertensionpreeclampsia.
Am J Obstet Gynecol. 2012;206(6):470-5.
Qasqas SA, McPherson C, Frishman WH, Elkayam U.
Cardiovascular pharmacotherapeutic considerations during
pregnancy and lactation. Cardiol Rev. 2004;12(4):201-21.
Magee L, von Dadelszen P. Prevention and treatment of
postpartum hypertension. Cochrane Database of Systematic
Reviews. 2013;4:CD004351.
Dennis AT. Management of pre-eclampsia: issues for
anaesthetists. Anaesthesia. 2012;67(9):1009-20.
Toirac A, Pascual V, Deulofeu I, Mastrapa K, Torres Y.
Hipertensión arterial durante el embarazo, el parto y el
puerperio. Medisan. 2010;14(5):685-701.
Foo L, Tay J, Lees CC, McEniery CM, Wilkinson IB. Hypertension
in Pregnancy: Natural History and Treatment Options. Curr
Hypertens Rep. 2015;17(5):36.
Agudelo ML, Agudelo LM, Castaño JJ, Giraldo JF, Hoyos AF,
Lara AM, et al. Prevalencia de los trastornos hipertensivos
del embarazo en mujeres embarazadas controladas en
ASSBASALUD E.S.E. Manizales (Colombia), 2006 a 2008. Arch
Med Manizales. 2010;10(2)130-50.
Garovic VD, Hayman SR. Hypertension in pregnancy: an
emerging risk factor for cardiovascular disease. Nat Clin Pract
Nephrol. 2007;3(11):613-22.
Morris EA, Hale SA, Badger GJ, Magness RR, Bernstein IM.
Pregnancy induces persistent changes in vascular compliance
in primiparous women. Am J Obstet Gynecol. 2005;212(5):633.
e1-6.
Kaaja RJ, Greer IA. Manifestations of Chronic Disease During
Pregnancy. JAMA. 2005;294(21):2751-7.
Royal College of Obstetricians and Gynaecologists. Hypertension
in pregnancy: the management of hypertensive disorders during
pregnancy. NICE Clinical Guidelines. London: Royal College of
Obstetricians and Gynaecologists; 2010.
Ghanem FA, Movahed A. Use of antihypertensive drugs during
pregnancy and lactation. Cardiovasc Ther. 2008;26(1):38-49
Magriples U, Boynton MH, Kershaw TS, Duffany KO, Rising
SS, Ickovics JR. Blood pressure changes during pregnancy:
impact of race, body mass index, and wight gain. Am J Perinatol.
;30(5):415-24.
Ghuman N, Rheiner J, Tendler BE, White WB. Hypertension in
the postpartum woman: clinical update for the hypertension
specialist. J Clin Hypertens (Greenwich). 2009;11(12):726-33.
Santana G. Hipertensión arterial en el puerperio. Rev medica
electron. 2012;34(2):186-98.
Velásquez JA. Hipertensión posparto. Rev colomb obstet ginecol.
;56(2):141-6.
von Dadelszen P, Menzies J, Gilgoff S, Xie F, Douglas
MJ, Sawchuck D, et al. Evidence-based management for
preeclampsia. Front Biosci. 2007;12:2876-89.
Prabhu TR. Cerebrovascular complications in pregnancy and
puerperium. J Obstet Gynaecol India. 2013;63(2):108-11.
Yücesoy G, Özkan S, Bodur H, Tan T, Çalişkan E, Vural B, et
al. Maternal and perinatal outcome in pregnancies complicated
with hypertensive disorder of pregnancy: a seven year
experience of a tertiary care center. Arch Gynecol Obstet.
;273(1):43-9.
Orehek EK, Burns JD, Koyfman F, Azocar RJ, Holsapple JW,
Green DM. Postpartum trifecta: simultaneous eclamptic
intracerebral hemorrhage, PRES, and herniation due to
intracranial hypotension. Neurocrit Care. 2012;17(3):434-8.
Spaan J, Peeters L, Spaanderman M, Brown M. Cardiovascular
Risk Management After a Hypertensive Disorder of Pregnancy.
Hypertension. 2012;60(6):1368-73.
Romero-Arauz JF, Morales-Borrego E, García-Espinosa M,
Peralta-Pedrero ML. Guía de práctica clínica: Preeclampsia-
Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the
NHLBI Working Group on Research on Hypertension During
Pregnancy. Hypertension. 2003;22(2):109-27.
Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM.
Delayed postpartum preeclampsia: An experience of 151 cases.
Am J Obstet Gynecol. 2004;190(5):1464-6.
Sibai BM, Barton JR. Expectant management of severe
preeclampsia remote from term: patient selection, treatment,
and delivery indications. Am J Obstet Gynecol. 2007;196(6):514.
e1-9.
Sibai BM, Stella CL. Diagnosis and management of atypical
preeclampsia-eclampsia. Am J Obstet Gynecol. 2009;200(5):481.
e1-7.
Sibai BM. Management of late preterm and early-term
pregnancies complicated by mild gestational hypertension/preeclampsia.
Semin Perinatol. 2011;35(5):292-6.
Sibai BM. diagnosis and management of gestational hypertension
and preeclampsia. Obstet Gynecol. 2003;102(1):181-92.
Barton JR, Sibai BM. Pediction and Prevention of Recurrent
Preeclampsia. Obstet Gynecol. 2008;112(2):359-72.
Fontenot MT, Lewis DF, Frederick B, Wang Y, DeFranco EA,
Groome LJ, et al. A prospective randomized trial of magnesium
sulfate in severe preeclampsia: Use of diuresis as a clinical
parameter to determine the duration of postpartum therapy. Am
J Obstet Gynecol. 2005;192(6):1788-94.
Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium
supplementation during pregnancy for preventing hypertensive
disorders and related problems. Cochrane Database of Sys Rev.
;(8): CD001059.
Vila C, Pipa A, Portugal A, Campos S. Management of
postpartum hypertension. Int J Gynaecol Obstet. 2009;107
Suppl 2:S413-S729.
Sibai BM. Calcium supplementation during pregnancy reduces
risk of high blood pressure, pre-eclampsia and premature birth
compared with placebo?. Evid Based Med. 2011;16(2):40-1.
Rios FG, Risso-Vázquez A, Alvarez J, Vinzio M, Falbo P,
Rondinelli N, et al. Clinical Characteristics and outcomes of
obstetric patients admitted to the intensive care unit. Int J
Gynaecol Obstet. 2012;119(2):136-40.
Graeber B, Vanderwal T, Stiller RJ, Werdmann MJ. Late
postpartum eclampsia as an obstetric complication seen in the
ED. Am J Emerg Med. 2005;23(2):168-70.
Yancey LM, Withers E, Bakes K, Abbott J. Postpartum
preeclampsia: emergency department presentation and
management. J Emerg Med. 2011;40(4):380-4.
Firoz T, Melnik T. Postpartum evaluation and long term
implications. Best Pract Res Clin Obstet Gynaecol.
;25(4):549-61.
Di Marco I, Basualdo MN, Di Pietrantonio E, Paladino S,
Inglide M, Domergue G, et al. Guía de Práctica Clínica: Estados
hipertensivos del embarazo 2010. Rev. Hosp. Mat. Inf. Ramón
Sardá. 2011;30(1):70-93.
Noronha-Neto C, Katz L, Coutinho IC, Maia SB, Souza AS,
Amorim MM. Clonidine versus captopril for treatment of
postpartum very high blood pressure: study protocol for a
randomized controlled trial (CLONCAP). Reprod Health.
;10:37.
Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV,
Martins-Costa S, et al. The impact of prior preeclampsia on the
risk of superimposed preeclampsia and other adverse pregnancy
outcomes in patients with chronic hypertension. Am J Obstet
Gynecol. 2011;204(4):345.e1-6.
Dhakal G, Subedi M, Paudel K. Magnesium Sulphate in
Management of Severe Pre-eclampsia and Eclampsia. J Nepal
Health Res Counc. 2012;10(21):113-7.
Ascarelli MH, Johnson V, McCreary H, Cushman J, May WL,
Martin JN Jr. Postpartum preeclampsia management with
furosemide: a randomized clinical trial. Obstet Gynecol.
;105(1):29-33.
Sibai BM. Diagnosis, prevention, and management of eclampsia.
Obstet Gynecol. 2005;105(2):402-10.
Barrilleaux PS, Martin JN Jr, Klauser CK, Bufkin L, May
WL. Postpartum intravenous dexamethasone for severely
preeclamptic patients without hemolysis, elevated liver
enzymes, low platelets (HELLP) syndrome: a randomized trial.
Obstet Gynecol. 2005;105(4):843-8.
Jim B, Sharma S, Kebede T, Acharya A. Hypertension
in pregnancy: a comprehensive update. Cardiol Rev.
;18(4):178-89.
Vigil-De Gracia P, Ruiz E, López JC, de Jaramillo IA, Vega-Maleck JC,
Pinzón J. Management of severe hypertension in the postpartum
period with intravenous hydralazine or labetalol: a randomized
clinical trial. Hypertens Pregnancy. 2007;26(2):163-71.
Fletcher JJ, Kramer AH, Bleck TP, Solenski NJ. Overlapping
features of eclampsia and postpartum angiopathy. Neurocrit
Care. 2009;11(2):199-209.
Fanelli C, Fernandes BH, Machado FG, Okabe C, Malheiros DM,
Fujihara CK, et al. Effects of losartan, in monotherapy or in
association with hydrochlorothiazide, in chronic nephropathy
resulting from losartan treatment during lactation. Am J Physiol
Renal Physiol. 2011;301(3):F580-7.
Ruiz R, Gil R. Hipertensión arterial post-parto. Rev Med La Paz.
;20(1):28-33.
James PA, Oparil S, Carter BL, Cushman WC, DennisonHimmelfarb
C, Handler J, et al. 2014 Evidence-Based Guidelines
for the Management of High Blood Pressure in Adults. Report
From the Panel Members Appointed to the Eighth Joint National
Committee (JNC 8). JAMA. 2014;311(5):507-20.
Toirac AS, Pascual V, Deulofeu I, Mastrapa K, Torres Y.
Hipertensión arterial durante el emabarazo, el parto y el
puerperio. MEDISAN [Internet]. 2010 [Citado 17 Julio
;14(5). Disponible en: http://bvs.sld.cu/revistas/san/
vol_14_5_10/san13510.htm
Turner JA. Diagnosis and management of pre-eclampsia: an
update. Int J Womens Health. 2010;2:327-37.
Magee LA, Abalos E, von Dadelszen P, Sibai B, Easterling T,
Walkinshaw S, et al. How to manage hypertension in pregnancy
effectively. Br J Clin Pharmacol. 2011;72(3):394-401.
Eyal S, Kim JD, Anderson GD, Buchanan ML, Brateng DA, Carr
D, et al. Atenolol pharmacokinetics and excretion in breast milk
during the first 6 to 8 months postpartum. J Clin Pharmacol.
;50(11):1301-9.
Anderson GD, Carr DB. Effect of Pregnancy on the
Pharmacokinetics of Antihypertensive Drugs. Clin
Pharmacokinet. 2009;48(3):159-68.
Podymow T, August P. Update on the use of antihypertensive
drugs in pregnancy. Hypertension. 2008;51(4):960-9.
Podymow T, August P. Antihypertensive drugs in pregnancy.
Semin Nephrol. 2011;31(1):70-85.
Podymow T, August P, Umans JG. Antihypertensive therapy in
pregnancy. Semin Nephrol. 2004;24(6):616-25.
Koual M, Abbou H, Carbonnel M, Picone O, Ayoubi JM. Shortterm
outcome of patients with preeclampsia. Vasc Health Risk
Manag. 2013;9:143-8.
James PR, Nelson-Piercy C. Management of hypertension before,
during, and after pregnancy. Heart. 2004;90:1499-1504.
Duley L,Meher S, Jones L. Drugs for treatment of very high blood
pressure during pregnancy. Cochrane Database of Systematic
Reviews [Internet]. 2013 [Citado 17 Julio 2015], Issue 7. Art.
No.: CD001449. Disponible en: http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD001449.pub3/pdf
Barton JR, Barton LA, Istwan NB, et al. Elective delivery at 340/7
to 366/7 weeks’ gestation and its impact on neonatal outcomes
in women with stable mild gestational hypertension. Am J
Obstet Gynecol. 2011;204:44.e1-5.
Sibai BM, Koch MA, Freire S, et al. The impact of prior
preeclampsia on the risk of superimposed preeclampsia and
other adverse pregnancy outcomes in patients with chronic
hypertension. Am J Obstet Gynecol. 2011;204(4):345.e1-6.
Clark SL. Strategies for Reducing Maternal Mortality. Semin
Perinatol. 2012;36:42-7.
Fontenla A, García-Donaire JA, Hernández F, Segura J, Salgado
R, Cerezo C, et al. Management of Resistant Hypertension in
a Multidisciplinary Unit of Renal Denervation: Protocol and
Results. Rev Esp Cardiol. 2013;66(5):364-70.
Clark SL, Hankins GDV. Preventing Maternal Death: 10 Clinical
Diamonds. Obstet Gynecol. 2012;119(2 Pt1):360-4.
Spaan JJ, Sep SJS, Lopes van Balen V, Spaanderman MEA, Peeters
LLH. Metabolic Syndrome as a Risk Factor for Hypertension
After Preeclampsia. Obstet Gynecol. 2012;120:311-7.
Sibai BM. Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia.
Semin Perinatol. 2011;35(5):292-6.
McCarthy F, Kenny LC. Hypertension in pregnancy. Obstet
Gynaecol Reprod Med. 2015;25(8):229-35.